Literature DB >> 26093623

Case report: MR imaging features of disseminated uterine leiomyosarcoma presenting after hysterectomy with morcellation.

Tadi Ciszak1, Pardeep K Mittal1, Patrick Sullivan2, Kenneth Cardona2, Krisztina Z Hanley3, Namita Khanna4, Courtney Coursey Moreno5.   

Abstract

A 53-year-old woman underwent elective hysterectomy for symptomatic anemia secondary to abnormal uterine bleeding. She presented 15 months later with complaints of abdominal fullness. Abdominopelvic magnetic resonance imaging demonstrated multiple confluent enhancing solid masses centered in the pelvis and extending cranially to the level of the umbilicus. Additional separate nodules also were visible along the peritoneum. Biopsy demonstrated leiomyosarcoma. Additional clinical information was obtained, which revealed that the patient's prior hysterectomy was performed with morcellation. In November 2014, the United States Food and Drug Administration issued a warning discouraging the use of morcellation during hysterectomy and myomectomy because of the risk of seeding unsuspected malignancy. Radiologists should be aware of this potential complication of morcellation and its imaging appearance so that the correct diagnosis can be suggested in the imaging report.

Entities:  

Keywords:  Leiomyoma; Leiomyosarcoma; Magnetic resonance imaging; Morcellation

Mesh:

Year:  2015        PMID: 26093623     DOI: 10.1007/s00261-015-0486-9

Source DB:  PubMed          Journal:  Abdom Imaging        ISSN: 0942-8925


  2 in total

1.  Occult Malignancy Rate of 1498 Hysterectomies or Myomectomies with Morcellation: A Retrospective Single-Arm Study.

Authors:  Garri Tchartchian; Bernd Bojahr; Sven Becker; Attilio Di Spiezio Sardo; Vasilis Tanos; Hugo C Verhoeven; Markus Wallwiener; Rudy L De Wilde
Journal:  J Obstet Gynaecol India       Date:  2018-12-04

2.  Embryonal rhabdomyosarcoma within abdomen and pelvis in an adult.

Authors:  Zhimin Hao; Sufen Yang
Journal:  Int J Immunopathol Pharmacol       Date:  2018 Jan-Dec       Impact factor: 3.219

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.